{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-001319","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2025-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.238421+00:00","generated_at":"2026-05-25T03:43:55.746838+00:00","sec_items":["1.01","2.02","2.03","4.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Profound Medical restates Q1-Q3 2024 financials due to $472k revenue error; Q4 revenue up 108% YoY","bullets":["Revenue overstated by $472k in Q1 2024; prior 6-K filings for Q1-Q3 2024 no longer reliable.","Q4 2024 revenue $4.2M (+108% YoY); net loss $4.9M ($0.20/share) vs $8.9M ($0.42) in Q4 2023.","Full year 2024 revenue $10.7M; net loss $27.8M ($1.12/share) vs $28.3M ($1.34) in 2023.","New $10M CIBC revolving credit line matures March 2027; option to increase to $15M if trailing revenue exceeds $15M.","Mathieu Burtnyk promoted to President; Tom Tamberrino appointed CCO; CAPTAIN trial enrollment complete."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-001319","json":"https://secwatch.observer/filing/0001171843-25-001319.json","markdown":"https://secwatch.observer/filing/0001171843-25-001319.md","text":"https://secwatch.observer/filing/0001171843-25-001319.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325001319/0001171843-25-001319-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325001319/f8k_030725.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T03:43:55.746838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}